Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

LTRN

Lantern Pharma Inc.

Healthcare · USD

Set alert

Price alert · LTRN

All alert types
0.66 USD -0.07 -9.60%
As of Oct 30, 2026 Extended hours 0.66 0.00%
Bid
0.66 × 1
Ask
0.67 × 1
0.635 Day range 0.7409
0.624 52-week range 4.17
YTD
-78.19%
1 year
-83.36%
Open
0.728
Prev close
0.731
Mkt cap
9.87M
Vol
218.53K
Avg vol
230.70K
EPS
-1.63
P/E
0.00
Div yield
0.00%
More statistics
Low
0.635
High
0.7409
Forward P/E
-1.50
Beta
1.57
Short ratio
4.74
Inst. own
24.10%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
3.41
200-d avg
4.86
1y target
20.50

5D chart

Chart tools
Interval
1m5m15m30m
LTRN five-day price chart0.590.650.720.780.84Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-22.93 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.9×
FY 2018: -53.4×FY 2019: -38.3×FY 2020: -20.3×FY 2021: -7.1×FY 2022: -4.6×FY 2023: -2.9×FY 2024: -0.0×FY 2025: -1.9×
FY 2018 5y median -2.9× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 5.1×
FY 2018: -461×FY 2019: 99.3×FY 2020: 6.1×FY 2021: 1.2×FY 2022: 1.2×FY 2023: 1.1×FY 2024: 1.6×FY 2025: 5.1×
FY 2018 5y median 1.2× FY 2025
P/FCF -2.1×
FY 2018: -73.1×FY 2019: -43.9×FY 2020: -21.1×FY 2021: -8.2×FY 2022: -5.1×FY 2023: -3.2×FY 2024: -1.9×FY 2025: -2.1×
FY 2018 5y median -3.2× FY 2025
EV/EBITDA -6.3×
FY 2018: -53.5×FY 2019: -38.1×FY 2020: -17.0×FY 2021: -2.9×FY 2022: -0.0×FY 2023: -1.5×FY 2024: -1.3×FY 2025: -6.3×
FY 2018 5y median -1.5× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -47.5%
FY 2018: -1.4%FY 2019: -2.3%FY 2020: -4.7%FY 2021: -12.2%FY 2022: -19.5%FY 2023: -31.0%FY 2024: -51.9%FY 2025: -47.5%
FY 2018 5y median -31.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -262.0%
FY 2018: 855.5%FY 2019: -257.4%FY 2020: -30.0%FY 2021: -17.3%FY 2022: -25446.9%FY 2023: -39.0%FY 2024: -98.1%FY 2025: -262.0%
FY 2018 5y median -98.1% FY 2025
ROIC -21.1%
FY 2018: 855.5%FY 2019: -257.4%FY 2020: -29.8%FY 2021: -17.5%FY 2022: -25731.0%FY 2023: -43.5%FY 2024: -103.7%FY 2025: -21.1%
FY 2018 5y median -43.5% FY 2025
ROA -155.1%
FY 2018: -383.8%FY 2019: -169.5%FY 2020: -29.0%FY 2021: -16.7%FY 2022: -24236.6%FY 2023: -36.6%FY 2024: -81.3%FY 2025: -155.1%
FY 2018 5y median -81.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income 19.1%
FY 2018: 0.0%FY 2019: -40.6%FY 2020: -143.3%FY 2021: -113.1%FY 2022: -114522.9%FY 2023: 99.9%FY 2024: -24.3%FY 2025: 19.1%
FY 2018 FY 2025
EPS (diluted) 99.9%
FY 2018: 0.0%FY 2019: -39.3%FY 2020: -143.6%FY 2021: -18.9%FY 2022: -15.9%FY 2023: -12.2%FY 2024: -131255.1%FY 2025: 99.9%
FY 2018 FY 2025
Free Cash Flow 12.0%
FY 2018: 0.0%FY 2019: -67.8%FY 2020: -165.6%FY 2021: -87.1%FY 2022: -20.6%FY 2023: -12.3%FY 2024: -24.1%FY 2025: 12.0%
FY 2018 FY 2025

Financial Health

Current Ratio 2.4×
FY 2018: 0.7×FY 2019: 2.5×FY 2020: 36.6×FY 2021: 31.3×FY 2022: 21.0×FY 2023: 16.2×FY 2024: 5.8×FY 2025: 2.4×
FY 2018 5y median 16.2× FY 2025
Quick Ratio 2.4×
FY 2018: 0.7×FY 2019: 2.5×FY 2020: 36.6×FY 2021: 31.3×FY 2022: 21.0×FY 2023: 16.2×FY 2024: 5.8×FY 2025: 2.4×
FY 2018 5y median 16.2× FY 2025
Debt / Equity 12.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 12.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -4.3×
FY 2018: 0.3×FY 2019: 0.5×FY 2020: 3.2×FY 2021: 4.2×FY 2022: 0.0×FY 2023: 1.4×FY 2024: 0.4×FY 2025: -4.3×
FY 2018 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31